Thrombin-activatable Fibrinolysis Inhibitor (TAFI) as a Novel Prognostic Factor After Orthotropic Liver Transplantation: A Pilot Study. [electronic resource]
Producer: 20160330Description: 1912-4 p. digitalISSN:- 1873-2623
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.